Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
Anthi Maslarinou, Vangelis G. Manolopoulos, Georgia Ragia
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10

Showing 10 citing articles:

Pharmacogenetics of DPYD and treatment-related mortality on fluoropyrimidine chemotherapy for cancer patients: a meta-analysis and trial sequential analysis
Francisco Cézar Aquino de Moraes, Alícia Batista de Almeida Barbosa, Vitor Kendi Tsuchiya Sano, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study
Vasileios Fragoulakis, Rossana Roncato, Alessia Bignucolo, et al.
Pharmacological Research (2023) Vol. 197, pp. 106949-106949
Open Access | Times Cited: 12
Fluoropyrimidine Toxicity: the Hidden Secrets of DPYD
Vangelis G. Manolopoulos, Georgia Ragia
Current Drug Metabolism (2024) Vol. 25, Iss. 2, pp. 91-95
Closed Access | Times Cited: 3
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
Georgia Ragia, Anthi Maslarinou, Natalia Atzemian, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
MIR27A rs895819 TC Genotype Increases Risk of Fluoropyrimidine-Induced Severe Toxicity Independently of DPYD Variations
Georgia Ragia, Eirini Biziota, Triantafyllia Koukaki, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 2, pp. 59-67
Closed Access | Times Cited: 2
Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors
Jennifer Martin, Peter Galettis, Alex Flynn, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
Yasmín Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2548-2548
Open Access | Times Cited: 4
Enhancing breast cancer treatment through pharmacogenomics: A narrative review
Ram Mohan Ram Kumar, Suresh Joghee
Clinica Chimica Acta (2024) Vol. 562, pp. 119893-119893
Closed Access | Times Cited: 1
Correlation of Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics
Shanmugam Vippamakula, S. Sujatha, Pasumarthy Sree Mahalakshmi
(2024), pp. 121-156
Closed Access
MIR27A rs895819 CC Genotype Severely Reduces miR-27a Plasma Expression Levels
Georgia Ragia, Myria Pallikarou, Chrysoula Michou, et al.
Genes (2024) Vol. 15, Iss. 11, pp. 1491-1491
Open Access
Page 1

Scroll to top